MariMed Inc.

MRMD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $-1.2M $-198.9K $-1.8M $-7.4M $-535.6K $-809.5K $-377.4K
Depreciation & Amortization $363.0K $265.7K — — — — —
Depreciation $362.7K $265.7K $839.3K — — — —
Amortization — — $366.7K $20.0K — — —
Stock-Based Compensation $1.1M $163.6K $45.9K $36.0K $94.0K $164.0K $0
Net Cash from Operating Activities $1.8M $-197.9K $-392.9K $-455.2K $-10.7K $-127.5K $-181.3K
Investing Activities
Capital Expenditures $21.0M $3.4M — $-2.7K — — —
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $-20.9M $-3.3M $-3.5M $-379.7K $10.6K $17.2K —
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $19.9M $3.9M $3.1M $1.8M — — $300.1K
Net Change in Cash $720.9K $408.5K $-827.4K $979.7K $-46 $-110.2K $118.8K
Free Cash Flow $-19.2M $-3.6M — $-452.6K — — —
← Newer Page 2 of 2 Older →